Zacks Research Lifts Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Zacks Research raised their FY2024 earnings per share estimates for shares of Henry Schein in a research note issued on Tuesday, November 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $4.76 per share for the year, up from their previous forecast of $4.73. The consensus estimate for Henry Schein’s current full-year earnings is $4.78 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.21 EPS, Q1 2025 earnings at $1.17 EPS, Q2 2025 earnings at $1.28 EPS, Q3 2025 earnings at $1.31 EPS, Q4 2025 earnings at $1.40 EPS, FY2025 earnings at $5.15 EPS, Q1 2026 earnings at $1.35 EPS, Q2 2026 earnings at $1.39 EPS and FY2026 earnings at $5.61 EPS.

Several other equities analysts have also weighed in on the stock. Robert W. Baird cut their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. reduced their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.38.

Henry Schein Stock Performance

Shares of HSIC stock opened at $77.66 on Thursday. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock’s 50-day moving average is $71.26 and its two-hundred day moving average is $69.84. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market cap of $9.68 billion, a P/E ratio of 31.96, a PEG ratio of 2.20 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the firm earned $1.32 EPS. The company’s revenue was up .4% compared to the same quarter last year.

Insiders Place Their Bets

In related news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

Several hedge funds have recently modified their holdings of HSIC. Franklin Resources Inc. lifted its position in Henry Schein by 14.0% during the 3rd quarter. Franklin Resources Inc. now owns 37,637 shares of the company’s stock worth $2,673,000 after buying an additional 4,621 shares in the last quarter. Tidal Investments LLC grew its stake in shares of Henry Schein by 54.9% during the third quarter. Tidal Investments LLC now owns 13,942 shares of the company’s stock valued at $1,016,000 after purchasing an additional 4,939 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in Henry Schein in the 3rd quarter worth approximately $109,000. Virtu Financial LLC acquired a new position in Henry Schein during the 3rd quarter worth $239,000. Finally, TCW Group Inc. boosted its position in Henry Schein by 6.6% in the 3rd quarter. TCW Group Inc. now owns 26,368 shares of the company’s stock valued at $1,922,000 after buying an additional 1,628 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.